NewAmsterdam Pharma Company N.V.

NAMS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$538,407$563,864$748,420$771,743
Short-Term Investments$164,539$175,298$60,057$62,447
Receivables$20,249$0$1,613$21,305
Inventory$0$0$0$0
Other Curr. Assets$1,308$19,750$0$0
Total Curr. Assets$732,328$769,850$817,304$863,413
Property Plant & Equip (Net)$569$620$607$673
Goodwill$0$0$0$0
Intangibles$439$470$502$534
Long-Term Investments$53,091$44,172$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$54,099$45,262$1,109$1,207
Other Assets$0$0$0$0
Total Assets$786,427$815,112$818,413$864,620
Liabilities
Payables$3,632$5,895$6,087$4,744
Short-Term Debt$181$0$252$246
Tax Payable$0$0$0$0
Deferred Revenue$0$0$3,030$6,008
Other Curr. Liab.$48,589$20,932$29,577$91,033
Total Curr. Liab.$58,272$36,512$40,913$106,918
LT Debt$85$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$85$103$137$202
Other Liabilities$0$0$0$0
Cap. Leases$266$328$0$448
Total Liabilities$58,357$36,615$41,050$107,120
Equity
Pref Stock$0$0$0$0
Common Stock$14,107$14,014$13,968$13,444
Retained Earnings$0-$615,462-$598,098$0
AOCI$4,640$4,327$4,434$4,467
Other Equity$709,323$0$0$739,589
Total Equity$728,070$778,497$777,363$757,500
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$786,427$815,112$818,413$864,620
Net Debt-$538,141-$563,864-$748,168-$771,497
NewAmsterdam Pharma Company N.V. (NAMS) Financial Statements & Key Stats | AlphaPilot